Skip to main content

Table 2 Anti-malarial treatment practices for febrile children under 5 years of age stratified by the availability of diagnostics, use and result of malaria test

From: Changes in health workers' malaria diagnosis and treatment practices in Kenya

Children aged < 5 years

Health facilities with diagnostics

Health facilities without diagnostics

All health facilities

 

Positive

test

N = 91 (%)

Negative

test

N = 99 (%)

Test

not done

N = 377 (%)

All children

N = 407 (%)

Total

N = 974 (%)

AL

68 (74.7)

40 (40.4)

229 (60.7)

282 (69.3)

619 (63.6)

AL+QN

17 (18.7)

6 (6.1)

22 (5.8)

16 (4.0)

61 (6.3)*

QN

5 (5.5)

3 (3.0)

10 (2.7)

8 (2.0)

26 (2.7)

SP

0

5 (5.1)

8 (2.1)

1 (0.3)

14 (1.4)

AQ

0

2 (2.0)

4 (1.1)

0

6 (0.6)

QN+SP

1 (1.1)

0

0

0

1 (0.1)

No AM prescribed

0

43 (43.4)

104 (27.6)

100 (24.6)

247 (25.4)

Any AM prescribed

91 (100)

56 (56.6)

273 (72.4)

307 (75.4)

727 (74.6)

Antibiotic prescribed

70 (76.9)

89 (89.9)

281 (74.5)

329 (80.8)

769 (79.0)

  1. *All QN treatments as part of AL+QN therapy include administration of injectable quinine
  2. AL, artemether-lumefantrine; AQ, amodiaquine; SP, sulphadoxine-pyrimethamine; QN, quinine; AM, anti-malarial.